IonQ (IONQ) said Monday that its collaborative research with AstraZeneca (AZN), Amazon's (AMZN) AWS, and Nvidia (NVDA) achieved a 20 times speedup in quantum-classical computational chemistry simulations compared with prior demonstrations.
The project integrated IonQ's Forte quantum processor with Nvidia's CUDA-Q platform and AWS's Braket and ParallelCluster services. Designed to advance early-stage pharmaceutical development, the workflow cut computational runtimes from months to days while maintaining accuracy.
IonQ said the results will be presented at the ISC High Performance conference from June 10 to June 13 in Hamburg, Germany.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.